Essential thrombocythemia - a predisponent factor for stroke

AUTOR(ES)

Batista, Tânia Filipa Pereira

FONTE

Rev. Assoc. Med. Bras.

DATA DE PUBLICAÇÃO

22/07/2019

RESUMO

SUMMARY The essential thrombocythemia is one of the seven described forms of myeloproliferative neoplasms. It is characterized by megakaryocytic hyperplasia with consequent thrombocytosis maintained in the peripheral blood, favoring the occurrence of thrombo-hemorrhagic phenomena. We present the case of an 81-year-old woman with a history of ischemic stroke in the context of a sustained thrombocytosis, which led to a spinal study and a search for the V617F mutation in the JAK2 gene, which was positive. The patient started cytoreductive therapy with hydroxyurea with favorable current evolution.

Documentos Relacionados

• Perspectives on thrombosis in essential thrombocythemia and polycythemia vera: is leukocytosis a causative factor?
• Essential thrombocythemia: a rare disease in childhood
• Evidence for the involvement of B lymphoid cells in polycythemia vera and essential thrombocythemia.
• An altered platelet granule glycoprotein in patients with essential thrombocythemia.
• Migraine may be a risk factor for stroke